LGALS3 and non-small cell lung carcinoma: Among these secreted proteins, galectin-3 exhibits high expression levels in non-small cell lung cancer (NSCLC), and galectin-3 deficiency or pharmacological blockade significantly inhibits lung cancer progression [20].